- « Previous
- Clinical Pharmacology
- Next »
Aczone Gel
Clinical Pharmacology
Aczone Gel
Table 5 presents the mean percent reduction in inflammatory, non-inflammatory, and total lesions from baseline to Week 12.
Table 5: Percent Reduction in Lesions from Baseline to Week
12
| Study 1 | Study 2 | |||
| ACZONE N=745 |
Vehicle N=740 |
ACZONE N=761 |
Vehicle N=764 |
|
| Inflammatory | 46% | 42% | 48% | 40% |
| Non- Inflammatory | 31% | 24% | 30% | 21% |
| Total | 38% | 32% | 37% | 29% |
The clinical studies enrolled about equal proportions of male and female subjects. Female patients tended to have greater percent reductions in lesions and greater success on the Global Acne Assessment Score than males. The breakdown by race in the clinical studies was about 73% Caucasian, 14% Black, 9% Hispanic, and 2% Asian. Efficacy results were similar across the racial subgroups.
Generic Name: Dapsone
- « Previous
- Clinical Pharmacology
- Next »
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Health Extras
Acne & Emotion
Almost everyone has a pimple or two sometime in their life. Research shows even mild acne can pack an emotional punch. See more WebMD Videos »
Aczone Gel
New & Updated
Slideshows
Updated & New
RxList does not provide medical advice, diagnosis or treatment.